Last update 08 May 2025

Shanghai Jintong Life Technology Co., Ltd.

Private Company|2020|Shanghai Shi, China

Overview

Tags

Congenital Disorders
Immune System Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
XO(Xanthine dehydrogenase)1

Related

1
Drugs associated with Shanghai Jintong Life Technology Co., Ltd.
Allopurinol
Target
XO
Mechanism
XO inhibitors
Active Org.
GlaxoSmithKline KK [+3]
Originator Org.
Sebela Ireland Ltd.
Active Indication
Gout [+2]
Inactive Indication
Acute myocardial infarction [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date19 Aug 1966
1
Clinical Trials associated with Shanghai Jintong Life Technology Co., Ltd.
CTR20181406
/ Active, not recruitingNot Applicable
盐酸那拉曲坦片随机、开放、两周期、两交叉健康人体空腹/餐 后状态下生物等效性试验--预试验
[Translation] A randomized, open-label, two-period, two-crossover bioequivalence study of naratriptan hydrochloride tablets in healthy volunteers in the fasting/fed state - a pilot study
100 Clinical Results associated with Shanghai Jintong Life Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Jintong Life Technology Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Jintong Life Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Jintong Life Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Allopurinol
 ( XO )		Hyperuricemia
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free